Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells

Blood

Volumn 87, Issue 11, 1996, Pages 4871-4878

  Glickstein, Hava ^b   Breuer, William ^b   Loyevsky, Mark ^b   Konijn, Abraham M ^b   Libman, Jacqueline ^b   Shanzer, Abraham ^b   Cabantchik, Z Ioav ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; HYDROXAMIC ACID;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CYTOSTASIS; CYTOTOXIC T LYMPHOCYTE; DNA STRAND BREAKAGE; IRON CHELATION; IRON OVERLOAD; MALARIA; MAMMAL CELL; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SCAVENGING SYSTEM; TROPHOZOITE;

EID: 0029945314     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4871.bloodjournal87114871     Document Type: Article

References (41)

1. Hershko C, Weatherall DJ: Iron-chelating therapy. Crit Rev Clin Lab Sci 26:303, 1988
2. Hider RC, Porter JB, Singh S: The design of therapeutically useful iron chelators, in Bergeron RJ, Brittenham GM (eds): The Development of Iron Chelators for Clinical Use: Tokyo, CRC, 1994, p 353
3. Raventos-Suarez C, Pollack S, Nagel RL: Plasmodium falciparum: Inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 31:919, 1982
4. Fritsch G, Treumer J, Spira DT, Jung A: Suppression of mouse infections with desferrioxamine B. Exp Parasitol 60:171, 1985
5. Pollack S, Rossan RN, Davidson DE, Escajadillo A: Desferrioxamine suppresses Plasmodium falciparum in Aoutus Monkeys. Proc Soc Exp Biol Med 184:162, 1987
6. Traore O, Carnevalle P, Kaptue-Noche L, M'Nbede J, Desfontaine M, Elion J, Labie D, Nagel R: Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am J Hematol 37:206, 1991
7. Gordeuk VR, Thuma PE, Brittenham GM, Zulu S, Simwanza G, Mhangu S, Flesch G, Parry D. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 79:308, 1992
8. Bunnag D, Poltera AA, Viravan C, Looareesuwan S, Harinasuta KT, Schindlery S: Plasmocidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Trop 52:59, 1992
9. Gordeuk VR, Brittenham GM, Thuma PE: Iron chelation as a chemotherapeutic strategy in the treatment of malaria, in Bergeron RJ, Brittenham GM (eds): The Development of Iron Chelators for Clinical Use: Boca Raton, FL, CRC, 1994, p 111
10. Lederman HM, Cohen A, Lee JWW, Freedman HM, Gelfand EW: Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64:748, 1984
11. Weaver J, Zhan H, Pollack S: Erythrocyte hemolysate interacts with ATP-Fe to form a complex containing-iron, ATP and 13800 MW polypeptide. Br J Haematol 83:138, 193
12. Rothman RJ, Serroni A, Farber JL: Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol 42:703, 1992
13. Gutteridge JM, Quinlan GJ, Swain J, Cox J: Ferrous ion formation by ferrioxamine prepared from aged desferrioxamine: A potential prooxidant property. Free Radic Biol Med 16:733, 1994
14. Fukuchi K, Tomahasu S, Tsuruoka N, Gomi K: Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett 350:139, 1994
15. Lytton SD, Mester B, Libman J, Shanzer A, Cabantchik ZI: Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood 84:910, 1994
16. Cabantchik ZI: Iron chelators as antimalarials. The biochemical basis of selective cylotoxicity. Parasitol Today 11:74, 1995
17. Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M, Tsafack A: Iron chelators. Mode of action as antimalarials. Acta Haematol 1996 (in press)
18. Hershko C, Cabantchik ZI: Control of malaria by drug-mediated iron deprivation. Ir J Med Sci 30:845, 1995
19. Gabay T, Ginsburg H: Hemoglobin denaturation and iron release in acidified red blood cell lysate. A possible source of iron for intraerythrocytic malaria parasites. Exp Parasitol 77:261, 1993
20. Loyevsky M, Lytton SD, Mester B, Libman J, Shanzer A, Cabantchik ZI: The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest 91:218, 1993
21. Lytton SD, Cabantchik ZI, Libman J, Shanzer A: Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. Mol Pharmacol 40:584, 1991
22. Trager W, Jensen JB: Continuous culture of human malaria parasites. Science 193:673, 1976
23. Rivadeneira EM, Wasserman M, Espinal C: Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J Protozool 30:367, 1983
24. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by semiautomated microdilution technique. Antimicrob Agents Chemother 16:710, 1979
25. 24a. Tallarida RJ, Murray RB (eds): Manual of Pharmacologie Calculations with Computer Programs. New York, NY, Springer-Verlag, 1987
26. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107, 1990
27. Breuer W, Kartman N, Riordan JR, Cabantchik ZI: Up modulation of CFTR expression in epithelial cells in culture. J Biol Chem 267:10465, 1992
28. Konijn AM, Levy R, Link G, Hershko C: A rapid and sensitive ELISA for serum ferritin employing a fluorescent substrate. J Immunol Methods 54:297, 1982
29. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
30. Breuer W, Epstejn S, Milgram P, Cabantchik ZI: Transport of iron and other related metals into cells as revealed by a fluorescent probe. Am J Physiol (Cell) 268:C1354, 1995
31. Breuer W, Epstejn S, Cabantchik ZI: Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 270:24209, 1995
32. Heppner DG, Hallaway PE, Kontoghiorghes GJ, Eaton JW: Antimalarial properties of orally active iron chelators. Blood 72:358, 1988
33. Cabantchik ZI: Properties of permeation pathways induced in the human red cell membrane by malaria parasites. Blood Cells 16:421, 1990
34. Lytton SD, Mester B, Dayan I, Glickstein H, Libman J, Shanzer A, Cabantchik ZI: Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity. Blood 81:214, 1993
35. Scheibel LW: In vitro inhibition of the human malaria parasite by selected lipophilic chelators. Prog Clin Biol Res 165:377, 1984
36. Scheibel LW, Adler A: Antimalarial activity of selected aromatic chelators. Mol Pharmacol 18:320, 1980
37. Crumbliss AL: Aqeuous solution equilibrium and kinetic studies of iron siderophore and Model Siderophore Complexes, in Winkelmann G (ed): Handbook of Microbial Iron Chelators: Boca Raton, FL, CRC, 1991, p 184
38. Maskill H: The Physical Basis of Organic Chemistry. Oxford, UK, Oxford University Press, 1985, p 195
39. Goodwin JF, CF Written: Chelation of ferrous sulphate solutions by Desferrioxamine B. Nature 205:281, 1965
40. Crichton RR, Ward RJ: Structure and Molecular Biology of iron-binding proteins and the regulation of free iron pools, in Laufer RB (ed): Iron and Human Diseases, Boca Raton, FL, CRC, 1992, p 23
41. Cabantchik ZI, Glickstein H, Milgram P, Breuer W: A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem 233:221, 1995